← Alle Rechtstexte

EU-Recht · · Quelle: EUR-Lex · In Kraft

In EUR-Lex öffnen
Schriftgröße: 100 %
Weitere Informationen und Metadaten

Veröffentlichte Fassung · 32001D0660 · CELEX: 32001D0660

Rechtsstatus des zugrunde liegenden Rechtsakts laut EUR-Lex: In Kraft.

Gültig ab: 30.08.2001

Metadatenstand: 21.10.2026

Commission Decision

of 6 August 2001

updating Decision 2000/112/EC with regard to distribution between antigen banks of antigen reserves

(notified under document number C(2001) 2472)

(Text with EEA relevance)

(2001/660/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field(1), as last amended by Council Decision 2001/12/EC(2), and in particular Article 14 thereof,

Having regard to Council Decision 91/666/EEC of 11 December 1991 establishing Community reserves of foot-and-mouth disease vaccines(3), as last amended by Commission Decision 2001/181/EC(4), and in particular Article 7 thereof,

Whereas:

(1) In conformity with Decision 91/666/EEC, the purchase of antigens is a part of the Community action to establish Community reserves of foot-and-mouth disease vaccines.

(2) Annex I to Decision 91/666/EEC details the quantities and subtypes of antigen of the foot-and-mouth disease virus to be stored in Community antigen reserves.

(3) By Commission Decision 93/590/EC(5), as last amended by Decision 2000/112/EC(6), arrangements were made for purchase of A5, A22 and O1 foot-and-mouth disease virus antigens.

(4) By Commission Decision 97/348/EC(7), as last amended by Decision 2000/112/EC, arrangements were made for the purchase of A22-Iraq, C1 and ASIA1 foot-and-mouth disease virus antigens.

(5) By Commission Decision 2000/77/EC(8), arrangements were made for purchase of certain quantities of A Iran 96, A Iran 99, A Malaysia 97, SAT 1, SAT 2 (East African and Southern African strains) and SAT 3 foot-and-mouth disease virus antigen.

(6) By Commission Decision 2000/569/EC(9), arrangements were made for purchase of additional quantities of A22-Iraq, O1-Manisa, ASIA 1-Shamir, A Malaysia 97, SAT 1, SAT 2 (East African and Southern African strains) and SAT 3 foot-and-mouth disease virus antigen.

(7) Following written information from the contractor about the supply and distribution to the approved premises of the antigen purchased in accordance with Decision 2000/569/EC, it appears appropriate to update the Annex to Decision 2000/112/EC detailing the distribution between antigen banks of antigen reserves established within the framework of the Community action concerning reserves of foot-and-mouth disease vaccines and amending Commission Decisions 93/590/EC and 97/348/EC.

(8) The measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Committee,

HAS ADOPTED THIS DECISION:

Article 1

The Annex to Decision 2000/112/EC is replaced by Annex to this Decision.

Article 2

This Decision is addressed to the Member States.

Done at Brussels, 6 August 2001.

For the Commission

David Byrne

Member of the Commission

(1) OJ L 224, 18.8.1990, p. 19.

(2) OJ L 3, 6.1.2001, p. 27.

(3) OJ L 368, 31.12.1991, p. 21.

(4) OJ L 66, 8.3.2001, p. 39.

(5) OJ L 280, 13.11.1993, p. 33.

(6) OJ L 33, 8.2.2000, p. 21.

(7) OJ L 148, 6.6.1997, p. 27.

(8) OJ L 30, 4.2.2000, p. 35.

(9) OJ L 238, 22.9.2000, p. 61.

ANNEX

"ANNEX

>TABLE>"